Study guide

3.3 Dysrhythmias, ECG & ACLS

AACN CCRN Adult

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Strategy

1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy

2 Cardiovascular I — Hemodynamics & Shock

2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology

3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias

3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS

4 Respiratory I -- Failure, ABGs & Acute Conditions

4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma

5 Respiratory II — Mechanical Ventilation

5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications

6 Endocrine Emergencies

6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises

7 Renal & Genitourinary

7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy

8 Gastrointestinal

8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition

9 Hematology, Immunology & Integumentary

9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries

10 Neurological I — Stroke, TBI & ICP

10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring

11 Neurological II & Musculoskeletal

11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal

12 Behavioral & Psychosocial

12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

13 Multisystem I — Sepsis & MODS

13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response

14 Multisystem II — Trauma, Burns & Toxicology

14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies

15 Synergy Model, Advocacy & Caring

15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices

16 Collaboration, Systems Thinking & Diversity

16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning

17 Clinical Inquiry, Ethics & End-of-Life

17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care

3.3 Dysrhythmias, ECG & ACLS

Key Takeaways Explain This Topic AI

Shockable arrest rhythms are ventricular fibrillation and pulseless ventricular tachycardia; non-shockable rhythms are asystole and pulseless electrical activity, treated with CPR and epinephrine while reversing the H's and T's.

Defibrillation is unsynchronized (pulseless VF/VT); synchronized cardioversion is used for unstable rhythms with a pulse such as unstable SVT, atrial fibrillation/flutter, and monomorphic VT.

In refractory VF/pulseless VT, give epinephrine 1 mg every 3-5 minutes and amiodarone 300 mg after the second shock, then 150 mg.

Adenosine 6 mg rapid IV push (then 12 mg) treats stable regular narrow-complex SVT; atropine 1 mg every 3-5 minutes (max 3 mg) treats symptomatic bradycardia, with transcutaneous pacing if it fails.

Torsades de pointes is treated with IV magnesium sulfate; Mobitz II and third-degree (complete) AV block require pacing because they are unstable and unresponsive to atropine.

Last updated: July 2026

Systematic Rhythm Interpretation

Interpret every strip the same way: (1) determine the rate (300 divided by the number of large boxes between R waves for a regular rhythm), (2) assess regularity , (3) evaluate the P waves and their relationship to each QRS, (4) measure the PR interval (normal 0.12-0.20 seconds), and (5) measure the QRS width (normal under 0.12 seconds; a wide QRS suggests a ventricular or bundle-branch origin). This disciplined five-step read separates narrow- from wide-complex and organized from disorganized rhythms — the same axis that drives every ACLS decision at the bedside.

Lethal Arrest Rhythms

In cardiac arrest, the CCRN expects you to sort four rhythms into shockable and non-shockable because that decision drives the entire ACLS pathway.

Ventricular fibrillation (VF) — chaotic, disorganized ventricular activity with no effective contraction. Shockable.

Pulseless ventricular tachycardia (pVT) — organized wide-complex tachycardia with no pulse. Shockable.

Asystole — flatline, no electrical activity. Non-shockable.

Pulseless electrical activity (PEA) — organized electrical rhythm on the monitor but no palpable pulse. Non-shockable.

For shockable rhythms: deliver an immediate defibrillation (biphasic 120-200 J per manufacturer), resume high-quality CPR for 2 minutes, give epinephrine 1 mg IV every 3-5 minutes , and after the second shock give amiodarone 300 mg IV push (then 150 mg), or lidocaine as an alternative. For non-shockable rhythms: CPR, epinephrine as soon as possible , and aggressively search for and treat the reversible H's and T's (hypovolemia, hypoxia, hydrogen ion/acidosis, hypo-/hyperkalemia, hypothermia; tension pneumothorax, tamponade, toxins, thrombosis-pulmonary, thrombosis-coronary).

Defibrillation versus Synchronized Cardioversion

This distinction is heavily tested.

Defibrillation is UNsynchronized — it delivers a shock at any point in the cycle. Used for pulseless VF and pVT (and polymorphic/torsades where syncing is impossible).

Synchronized cardioversion times the shock to the R wave to avoid the vulnerable T wave (which could induce VF). Used for unstable rhythms that still have a pulse : unstable SVT, unstable atrial fibrillation or flutter, and stable-but-unstable monomorphic VT with a pulse. Signs of instability include hypotension, altered mentation, ischemic chest pain, and acute heart failure.

A monitored patient in wide-complex tachycardia who becomes pulseless needs immediate defibrillation , not cardioversion — once there is no pulse, the rhythm is treated as VF/pVT.

Tachydysrhythmias with a Pulse

Supraventricular tachycardia (SVT) — regular narrow-complex tachycardia (150-250/min). If stable : vagal maneuvers, then adenosine 6 mg rapid IV push followed by a saline flush; repeat 12 mg if needed. If unstable : synchronized cardioversion.

Atrial fibrillation — irregularly irregular, no discrete P waves. Atrial flutter — sawtooth flutter waves, often 2:1 or 4:1 conduction. Management: rate control with a beta-blocker or a non-dihydropyridine calcium channel blocker (diltiazem); rhythm control when indicated; and anticoagulation . Because atrial thrombus can form, any AF or flutter present more than 48 hours requires anticoagulation or a transesophageal echocardiogram to exclude clot before elective cardioversion . If the patient is unstable , perform immediate synchronized cardioversion.

Torsades de pointes — polymorphic VT with a twisting axis, associated with a prolonged QT. Treat with IV magnesium sulfate ; defibrillate if pulseless.

Other Common Rhythms

Premature ventricular contractions (PVCs) are early, wide beats; frequent multifocal PVCs, couplets, or the R-on-T phenomenon can herald ventricular tachycardia. Junctional rhythms arise from the AV node when the SA node fails, producing a narrow-complex rhythm at 40-60/min with absent, inverted, or retrograde P waves. Accelerated idioventricular rhythm (AIVR) is a benign, wide, slow rhythm (40-100/min) frequently seen as a reperfusion marker after successful PCI or fibrinolysis and usually needs no treatment. Recognizing these largely stable rhythms — and not reflexively shocking them — prevents unnecessary and harmful interventions.

Bradydysrhythmias and Heart Blocks

Symptomatic bradycardia (rate under 50 with hypotension, altered mentation, ischemic chest pain, or shock): first-line drug is atropine 1 mg IV every 3-5 minutes to a maximum of 3 mg . If atropine fails, use transcutaneous pacing and/or a chronotropic infusion (dopamine or epinephrine).

Heart blocks reflect delayed or failed AV conduction:

  • Block ECG Hallmark Stability/Treatment
  • First-degree PR interval over 0.20 s, constant Usually benign; observe

Second-degree Mobitz I (Wenckebach) Progressive PR lengthening, then a dropped QRS Often stable; atropine if symptomatic

Second-degree Mobitz II Constant PR, sudden dropped QRS Unstable; often pacing (may progress to complete block)

Third-degree (complete) Complete AV dissociation; P waves and QRS independent Emergency; transcutaneous/transvenous pacing

Atropine is often ineffective in Mobitz II and complete block because the lesion is below the AV node — go to pacing . Pacing modalities include transcutaneous (fastest, emergency, requires sedation/analgesia for capture discomfort), transvenous (temporary, more reliable), and epicardial wires placed after cardiac surgery. Always confirm electrical capture (a pacer spike followed by a wide QRS) and mechanical capture (a corresponding palpable pulse) — a spike without a pulse is failure to capture.

ACLS Drug Quick Reference

  • Drug Indication Dose
  • Epinephrine VF/pVT, asystole, PEA 1 mg IV every 3-5 min
  • Amiodarone Refractory VF/pVT 300 mg, then 150 mg
  • Adenosine Stable regular narrow-complex SVT 6 mg rapid push, then 12 mg
  • Atropine Symptomatic bradycardia 1 mg every 3-5 min, max 3 mg
  • Magnesium Torsades de pointes 1-2 g IV

A final trap: adenosine and cardioversion are for stable versus unstable SVT , but neither belongs in a pulseless rhythm — a patient with no pulse always follows the VF/pVT or PEA/asystole arrest algorithm.